Pulmonary monocyte kinetics in healthy volunteers and subjects with inflammatory arthritis
Monocytes are central to innate and adaptive immunity, regulating tissue homeostasis and inflammation. However, data on their steady-state biodistribution in healthy humans are limited. We developed a non-invasive method to track radiolabelled autologous monocytes. Monocytes showed distinct intravascular transit kinetics vs neutrophils, with 45 min recovery of 47% for neutrophils vs 7% for monocytes (p=0.008), indicating predominant distribution in marginated pools. In patients with psoriatic and rheumatoid arthritis but no documented lung disease, we observed preferential early retention of monocytes in the lungs (transit half-life 25.2 min vs 14.2 min; p=0.008) compared with healthy volunteers, with reduced intravascular recovery in patients with rheumatoid arthritis (4.3% vs 12%; p=0.0043). These findings provide the first direct evidence of human monocyte pulmonary transit kinetics, systemic biodistribution and fate in health and inflammatory disease, advancing understanding of in vivo monocyte biology.
Authors
- Rebecca C. Furze (ORCID: https://orcid.org/0000-0002-6498-2803)
- Nicholas Shenker (ORCID: https://orcid.org/0000-0002-9852-5811)
- Charlotte Summers (ORCID: https://orcid.org/0000-0002-7269-2873)
- Flavia Sunzini (ORCID: https://orcid.org/0000-0003-0775-9960)
- Huw D. Lewis
- Joseph Hutton
- Neda Farahi (ORCID: https://orcid.org/0000-0001-5793-3205)
- Edwin R. Chilvers (ORCID: https://orcid.org/0000-0002-4230-9677)
- Daniel Gillett
- Alex Tate
- Richard Hohne
- Jonathan Cavanagh
- Anthony YKC Ng
Institutions
- GlaxoSmithKline (United Kingdom) (GB)
- University of Cambridge (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Cambridge University Health Partners (GB)
- Imperial College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Thorax
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1136/thorax-2025-224226
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- Wellcome Trust
- UK Research and Innovation
- National Institute for Health and Care Research
- Evelyn Trust
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre